Effective Management of Nasal Vestibule Squamous Cell Carcinoma with Cemiplimab: A Case Report

Abstract

Nasal vestibule squamous cell carcinoma (SCC) is a rare malignancy with limited treatment options. This case report presents an 83-year-old female with SCC of the nasal vestibule who was ineligible for surgery or radiotherapy due to various factors. The patient was successfully treated with cemiplimab, a systemic anti-PD-1 antibody, resulting in a remarkable tumor reduction without any observed side effects. This is the first reported case of nasal vestibule SCC treated with cemiplimab, highlighting its potential as a promising therapeutic option.

Keywords

• cemiplimab
• squamous cell carcinoma
• immunotherapy
• skin cancer